Of Kangaroos And Bass: IPR Patent Challenges Going Awry
This article was originally published in Scrip
Executive Summary
As Scottish poet Robert Burns and American author John Steinbeck might have warned Kyle Bass, chief investment officer at Hayman Capital Management – the hedge fund manager the biopharmaceutical industry loves to hate – even the best-laid schemes can go awry.